首页 | 本学科首页   官方微博 | 高级检索  
检索        

化疗对晚期非小细胞肺癌患者凝血功能的影响
引用本文:徐春华,于力克.化疗对晚期非小细胞肺癌患者凝血功能的影响[J].陕西肿瘤医学,2011(1):65-66.
作者姓名:徐春华  于力克
作者单位:南京市胸科医院呼吸科,江苏南京210029
摘    要:目的:探讨晚期非小细胞肺癌(NSCLC)患者化疗前后凝血指标的变化及临床意义。方法:对60例肺癌患者及20例健康人的血浆凝血酶原时间(PT)、纤维蛋白原(FIB)、部分活化凝血活酶时间(APTT)和D-二聚体(D—D))水平进行测定,同时计数血小板(PLT)。结果:化疗前肺癌患者凝血指标凝血酶原时间、纤维蛋白原、部分活化凝血活酶时间、D-二聚体、血小板与正常对照组比较有显著差异(P〈0.05);肺癌患者化疗后与化疗前各项指标相比有显著性差异(P〈0.05)。结论:晚期NSCLC患者普遍存在凝血功能异常,化疗可改善患者的凝血功能。

关 键 词:非小细胞肺癌  化疗  凝血指标

The influence of chemotherapy on coagulation function in patients with advanced non - small cell lung cancer
Institution:XU Chun - hua, YU Li - ke (Department of Respiration, Nanjing Chest Hospital, Nanjing 210029, China.)
Abstract:Objective: To evaluate the variations of coagulation markers before and after chemotherapy in patients with advanced non - small cell lung cancer. Methods :The plasma levels of coagulation markers were detected in 60 patients with lung cancer and 20 normal controls. Results: Compared with the control group, the mean values of prothrombin time ( PT), fibrinogen ( FIB ), activated partial thromboplastin time ( APTT), D - dimer ( D - D ) and platelet count(PLT) were significantly increase (P 〈 0.05 )in patients with NSCLC. The expressive rates of coagulation mark- ers were lower in post - treatment patients than in pre - treatment samples ( P 〈 0.05 ). Conclusion: Coagulation disorder is common among advanced NSCLC patients. Chemotherapy may improve the coagulation function of patients with NSCLC.
Keywords:non- small cell lung cancer  chemotherapy  coagulation markers
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号